Toronto-Dominion Bank and TD Securities Inc. increase their stake in UroGen Pharma Ltd. to 5.9%, reflecting ongoing investment interest in the pharmaceutical sector.
| Name | UroGen Pharma Ltd. |
|---|---|
| CIK | 0001668243 |
| Tickers | URGN |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | L3 Israel |
| Phone | 972 9 770 7601 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Toronto-Dominion Bank and TD Securities Inc. increase their stake in UroGen Pharma Ltd. to 5.9%, reflecting ongoing investment interest in the pharmaceutical sector.
UroGen Pharma Ltd. increases securities under employee plans, enhancing talent retention in the pharmaceutical industry.
UroGen Pharma Ltd. releases third-quarter results, emphasizing growth in pharmaceutical preparations and strategic advancements in the industry.
UroGen Pharma Ltd. announces $68 million in Q3 revenue from ZUSDURI, a 35% increase, and FDA acceptance of UGN-103 NDA, enhancing growth prospects.
584 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947263-26-000091 | 005-89992 | 261554166 | 34 | 10868 | |||
| 2026-11-04 | S-8 | FORM S-8 | 0001437749-26-034945 | 333-299817 | 261522366 | 33 | 234840 | 1 | 1 | |
| 2026-11-04 | 10-Q | FORM 10-Q | 0001437749-26-034780 | 001-38079 | 261520349 | 34 | 8622720 | 1 | 1 | |
| 2026-11-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-034769 | 001-38079 | 261520128 | 34 | 244550 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003732 | 005-89992 | 261491564 | 34 | 10984 | |||
| 2026-10-09 | 4 | FORM 4 | 0001437749-26-032421 | 8325 | ||||||
| 2026-10-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-26-000887 | 001-38079 | 261451109 | 33 | 4420 | |||
| 2026-09-09 | 4 | FORM 4 | 0001437749-26-029965 | 8307 | ||||||
| 2026-09-09 | 4 | FORM 4 | 0001437749-26-029963 | 8308 | ||||||
| 2026-09-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-26-000811 | 001-38079 | 261366683 | 33 | 4979 | |||
| 2026-09-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-26-000810 | 001-38079 | 261366680 | 33 | 4383 | |||
| 2026-08-28 | 4 | FORM 4 | 0001437749-26-029175 | 6510 | ||||||
| 2026-08-24 | 4 | FORM 4 | 0001437749-26-028840 | 4866 | ||||||
| 2026-08-20 | 144 | xsl144X01/primary_doc.xml | 0001000275-26-000100 | 001-38079 | 261298726 | 33 | 5376 | |||
| 2026-08-20 | 8-K | FORM 8-K | 8.01 | 0001437749-26-028590 | 001-38079 | 261297246 | 34 | 151391 | 1 | 1 |
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947263-26-000072 | 005-89992 | 261267574 | 34 | 10864 | |||
| 2026-08-05 | 10-Q | FORM 10-Q | 0001437749-26-025794 | 001-38079 | 261241410 | 34 | 8875480 | 1 | 1 | |
| 2026-08-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-025793 | 001-38079 | 261241406 | 34 | 267474 | 1 | 1 |
| 2026-07-10 | 4 | FORM 4 | 0001437749-26-023290 | 5127 | ||||||
| 2026-07-09 | 144 | xsl144X01/primary_doc.xml | 0001000275-26-000093 | 001-38079 | 261165893 | 33 | 5562 | |||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021523 | 5043 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021519 | 7577 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021517 | 7630 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021515 | 5182 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021513 | 7613 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021511 | 7593 | ||||||
| 2026-06-24 | 4 | FORM 4 | 0001437749-26-021509 | 5208 | ||||||
| 2026-06-23 | 8-K | FORM 8-K | 3.03,5.02,5.07,9.01 | 0001437749-26-021442 | 001-38079 | 261111182 | 34 | 683750 | 1 | 1 |
| 2026-06-22 | 144 | xsl144X01/primary_doc.xml | 0001000275-26-000079 | 001-38079 | 261106862 | 33 | 4936 | |||
| 2026-06-09 | 4 | FORM 4 | 0001437749-26-019964 | 8304 | ||||||
| 2026-06-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-26-000558 | 001-38079 | 261074633 | 33 | 4982 | |||
| 2026-06-02 | 8-K | FORM 8-K | 8.01 | 0001437749-26-019102 | 001-38079 | 261053665 | 34 | 151340 | 1 | 1 |
| 2026-05-27 | ARS | FORM ARS | 0001437749-26-018538 | 001-38079 | 261026029 | 34 | 9320262 | |||
| 2026-05-27 | 4 | FORM 4 | 0001437749-26-018442 | 6513 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062615 | 005-89992 | 26988230 | 34 | 12419 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947263-26-000047 | 005-89992 | 26985423 | 34 | 10664 | |||
| 2026-05-11 | 4 | FORM 4 | 0001437749-26-016104 | 5039 | ||||||
| 2026-05-08 | 144 | xsl144X01/primary_doc.xml | 0001000275-26-000047 | 001-38079 | 26957241 | 33 | 4306 | |||
| 2026-05-06 | 10-Q | FORM 10-Q | 0001437749-26-015019 | 001-38079 | 26945892 | 34 | 9796491 | 1 | 1 | |
| 2026-05-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-015018 | 001-38079 | 26945884 | 34 | 257978 | 1 | 1 |
| 2026-04-30 | DEF 14A | FORM DEF 14A | 0001437749-26-014237 | 001-38079 | 26926242 | 34 | 3611265 | 1 | 1 | |
| 2026-04-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001661 | 005-89992 | 26901033 | 34 | 10817 | |||
| 2026-04-17 | PRE 14A | FORM PRE 14A | 0001437749-26-012685 | 001-38079 | 26871611 | 34 | 3596620 | 1 | 1 | |
| 2026-03-02 | 10-K | FORM 10-K | 0001437749-26-006234 | 001-38079 | 26703573 | 34 | 10654180 | 1 | 1 | |
| 2026-03-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-006233 | 001-38079 | 26703561 | 34 | 267294 | 1 | 1 |
| 2026-03-02 | 8-K | 8-K | 1.01,2.03 | 0001193125-26-084282 | 001-38079 | 26703554 | 34 | 145972 | 1 | 1 |
| 2026-02-27 | 4 | FORM 4 | 0001437749-26-006124 | 6375 | ||||||
| 2026-02-19 | 4 | FORM 4 | 0001437749-26-004638 | 5179 | ||||||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947263-26-000006 | 005-89992 | 26630782 | 34 | 7045 | |||
| 2026-02-11 | 4 | FORM 4 | 0001437749-26-003778 | 20313 | ||||||
| 2026-02-04 | 4 | FORM 4 | 0001437749-26-003040 | 7211 | ||||||
| 2026-02-03 | 4 | FORM 4 | 0001437749-26-002843 | 15948 | ||||||
| 2026-02-03 | 4 | FORM 4 | 0001437749-26-002841 | 5183 | ||||||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001976408-26-000031 | 001-38079 | 26590178 | 33 | 5690 | |||
| 2025-12-01 | 4 | FORM 4 | 0001437749-25-036576 | 6342 | ||||||
| 2025-12-01 | 4 | FORM 4 | 0001437749-25-036565 | 6360 | ||||||
| 2025-12-01 | 4 | FORM 4 | 0001437749-25-036559 | 6376 | ||||||
| 2025-12-01 | 4 | FORM 4 | 0001437749-25-036557 | 6339 | ||||||
| 2025-12-01 | 4 | FORM 4 | 0001437749-25-036555 | 6323 | ||||||
| 2025-11-20 | 4 | FORM 4 | 0001437749-25-035821 | 4903 | ||||||
| 2025-11-19 | 144 | xsl144X01/primary_doc.xml | 0001000275-25-000163 | 001-38079 | 251498890 | 33 | 4930 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112620 | 005-89992 | 251487202 | 34 | 12264 | |||
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947263-25-000010 | 005-89992 | 251482925 | 34 | 7049 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001771015-25-000010 | 005-89992 | 251482920 | 34 | 6861 | |||
| 2025-11-06 | S-8 | S-8 | 0001193125-25-269706 | 333-291325 | 251458880 | 33 | 196828 | 1 | 1 | |
| 2025-11-06 | S-3ASR | S-3ASR | 0001193125-25-269643 | 333-291323 | 251458706 | 33 | 1524364 | 1 | 1 | |
| 2025-11-06 | 10-Q | FORM 10-Q | 0001437749-25-033468 | 001-38079 | 251456258 | 34 | 8821766 | 1 | 1 | |
| 2025-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-033466 | 001-38079 | 251456237 | 34 | 269106 | 1 | 1 |
| 2025-10-09 | 4 | FORM 4 | 0001437749-25-030772 | 8188 | ||||||
| 2025-09-09 | 4 | FORM 4 | 0001437749-25-028707 | 8175 | ||||||
| 2025-09-09 | 4 | FORM 4 | 0001437749-25-028705 | 8174 | ||||||
| 2025-09-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-25-000296 | 001-38079 | 251301892 | 33 | 5254 | |||
| 2025-09-09 | 144 | xsl144X01/primary_doc.xml | 0001976408-25-000295 | 001-38079 | 251301689 | 33 | 4660 | |||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027883 | 7440 | ||||||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027882 | 7493 | ||||||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027880 | 7458 | ||||||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027879 | 7426 | ||||||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027878 | 7456 | ||||||
| 2025-08-27 | 4 | FORM 4 | 0001437749-25-027877 | 5071 | ||||||
| 2025-08-27 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-25-027874 | 001-38079 | 251265763 | 34 | 449837 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022035 | 005-89992 | 251221581 | 34 | 12591 | |||
| 2025-08-13 | 4 | FORM 4 | 0001437749-25-026377 | 4695 | ||||||
| 2025-08-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-076875 | 005-89992 | 251207227 | 34 | 15910 | |||
| 2025-08-07 | 10-Q | FORM 10-Q | 0001437749-25-025243 | 001-38079 | 251191733 | 34 | 8537942 | 1 | 1 | |
| 2025-08-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-025242 | 001-38079 | 251191712 | 34 | 259210 | 1 | 1 |
| 2025-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000471 | 005-89992 | 251189301 | 34 | 7735 | |||
| 2025-08-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-072156 | 005-89992 | 251185946 | 34 | 19677 | |||
| 2025-07-30 | 4 | FORM 4 | 0001437749-25-023969 | 5337 | ||||||
| 2025-07-30 | 4 | FORM 4 | 0001437749-25-023963 | 6126 | ||||||
| 2025-07-30 | 4 | FORM 4 | 0001437749-25-023961 | 6129 | ||||||
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001085146-25-004272 | 005-89992 | 251162584 | 34 | 6554 | |||
| 2025-07-29 | 144 | xsl144X01/primary_doc.xml | 0001976408-25-000249 | 001-38079 | 251157558 | 33 | 4696 | |||
| 2025-07-29 | 144 | xsl144X01/primary_doc.xml | 0001976408-25-000248 | 001-38079 | 251157547 | 33 | 4113 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002462 | 005-89992 | 251128416 | 34 | 10739 | |||
| 2025-07-16 | ARS | ANNUAL REPORT | 0001437749-25-022781 | 001-38079 | 251126314 | 34 | 10303191 | |||
| 2025-07-15 | DEF 14A | FORM DEF 14A | 0001437749-25-022732 | 001-38079 | 251125370 | 34 | 2679196 | 1 | 1 | |
| 2025-07-03 | 8-K | 8-K | 5.02 | 0001193125-25-155503 | 001-38079 | 251105760 | 34 | 136013 | 1 | 1 |
| 2025-06-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-054819 | 005-89992 | 251050936 | 34 | 33194 | |||
| 2025-06-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001085146-25-003449 | 005-89992 | 251045238 | 34 | 6432 | |||
| 2025-06-13 | 8-K | 8-K | 8.01 | 0001193125-25-140339 | 001-38079 | 251044772 | 34 | 141194 | 1 | 1 |
| 2025-06-11 | 4 | FORM 4 | 0001437749-25-020045 | 8170 | ||||||
| 2025-06-10 | 144 | xsl144X01/primary_doc.xml | 0001976408-25-000193 | 001-38079 | 251036072 | 33 | 4112 | |||
| 2025-06-09 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001999371-25-007493 | 005-89992 | 251035555 | 34 | 36435 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-013190 | 005-89992 | 25954933 | 34 | 18753 | |||
| 2025-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002237 | 005-89992 | 25932849 | 34 | 12356 | |||
| 2025-05-12 | 10-Q | FORM 10-Q | 0001437749-25-015956 | 001-38079 | 25932693 | 34 | 8528765 | 1 | 1 | |
| 2025-05-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-015955 | 001-38079 | 25932682 | 34 | 255920 | 1 | 1 |
| 2025-04-30 | 10-K/A | FORM 10-K/A | 0001437749-25-013839 | 001-38079 | 25894727 | 34 | 920187 | 1 | 1 | |
| 2025-03-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001178913-25-000862 | 005-89992 | 25743535 | 34 | 8700 | |||
| 2025-03-10 | 10-K | FORM 10-K | 0001437749-25-006842 | 001-38079 | 25724249 | 34 | 10320747 | 1 | 1 | |
| 2025-03-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-006757 | 001-38079 | 25722201 | 34 | 263145 | 1 | 1 |
| 2025-02-20 | 8-K | 8-K | 1.01,3.02 | 0001193125-25-030143 | 001-38079 | 25643341 | 34 | 148148 | 1 | 1 |
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000866 | 005-89992 | 25612620 | 34 | 12311 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000235 | 005-89992 | 25591262 | 34 | 8005 | |||
| 2025-02-04 | 4 | FORM 4 | 0001437749-25-002688 | 20325 | ||||||
| 2025-02-04 | 4 | FORM 4 | 0001437749-25-002685 | 20320 | ||||||
| 2025-02-04 | 4 | FORM 4 | 0001437749-25-002683 | 5183 | ||||||
| 2025-01-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-005649 | 001-38079 | 25527736 | 34 | 18068027 | 1 | 1 |
| 2024-11-18 | SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001213900-24-099322 | 005-89992 | 241469702 | 34 | 90602 | |||
| 2024-11-14 | SC 13G/A | UROGEN PHARMA LTD. | 0000902664-24-006639 | 005-89992 | 241465281 | 34 | 65485 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119305 | 005-89992 | 241464743 | 34 | 92228 | |||
| 2024-11-14 | SC 13G/A | greatpoint-urgn093024a2.htm | 0001172661-24-005288 | 005-89992 | 241463680 | 34 | 110193 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001178913-24-003701 | 005-89992 | 241459163 | 34 | 99812 | |||
| 2024-11-14 | SC 13G/A | UROGEN PHARMA LTD. | 0000902664-24-006499 | 005-89992 | 241457000 | 34 | 66076 | |||
| 2024-11-13 | SC 13G/A | COWEN AND COMPANY, LLC | 0001085146-24-005686 | 005-89992 | 241457417 | 34 | 37358 | |||
| 2024-11-12 | SC 13G | UROGEN PHARMA LTD. | 0000902664-24-006395 | 005-89992 | 241444178 | 34 | 80217 | |||
| 2024-11-08 | SC 13G | il0011407140_110824.txt | 0002012383-24-003700 | 005-89992 | 241439848 | 34 | 13662 | |||
| 2024-11-06 | SC 13G | MS INITIAL | 0000895421-24-000502 | 005-89992 | 241430170 | 34 | 12599 | |||
| 2024-11-06 | 10-Q | FORM 10-Q | 0001437749-24-033454 | 001-38079 | 241429304 | 34 | 7698598 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-251712 | 001-38079 | 241429295 | 34 | 238121 | 1 | 1 |
| 2024-10-24 | SC 13G | il0011407140_102424.txt | 0002012383-24-002179 | 005-89992 | 241392090 | 34 | 13650 | |||
| 2024-10-09 | 4 | xslF345X05/form4-10092024_081051.xml | 0001415889-24-024932 | 7803 | ||||||
| 2024-10-09 | 3 | xslF345X02/form3-10092024_081043.xml | 0001415889-24-024930 | 8535 | ||||||
| 2024-10-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-234808 | 001-38079 | 241361537 | 34 | 275056 | 1 | 1 |
| 2024-09-24 | 8-K | 8-K | 2.03 | 0001193125-24-224801 | 001-38079 | 241320387 | 34 | 148947 | 1 | 1 |
| 2024-09-13 | 8-K | 8-K | 5.02 | 0001193125-24-218868 | 001-38079 | 241297934 | 34 | 143706 | 1 | 1 |
| 2024-09-12 | 4 | FORM 4 | 0001437749-24-029040 | 8182 | ||||||
| 2024-09-12 | 4 | FORM 4 | 0001437749-24-029038 | 8181 | ||||||
| 2024-09-12 | 4 | FORM 4 | 0001437749-24-029036 | 6630 | ||||||
| 2024-09-10 | 144 | xsl144X01/primary_doc.xml | 0001976408-24-000246 | 001-38079 | 241288744 | 33 | 4703 | |||
| 2024-08-15 | 8-K | 8-K | 8.01 | 0001193125-24-200993 | 001-38079 | 241210687 | 34 | 143038 | 1 | 1 |
| 2024-08-13 | S-8 | FORM S-8 | 0001437749-24-026414 | 333-281520 | 241202108 | 33 | 80329 | |||
| 2024-08-13 | 10-Q | FORM 10-Q | 0001437749-24-026161 | 001-38079 | 241198862 | 34 | 7285376 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-199425 | 001-38079 | 241198847 | 34 | 243147 | 1 | 1 |
| 2024-08-08 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-197008 | 001-38079 | 241188971 | 34 | 407004 | 1 | 1 |
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025299 | 5078 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025298 | 5037 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025297 | 5033 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025295 | 5052 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025293 | 5026 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025292 | 5049 | ||||||
| 2024-08-08 | 4 | FORM 4 | 0001437749-24-025291 | 5020 | ||||||
| 2024-07-09 | ARS | urgnars.pdf | 0001437749-24-022420 | 001-38079 | 241108203 | 34 | 9115552 | |||
| 2024-07-01 | DEFA14A | FORM DEFA14A | 0001437749-24-021723 | 001-38079 | 241090996 | 34 | 296028 | |||
| 2024-07-01 | DEF 14A | FORM DEF 14A | 0001437749-24-021722 | 001-38079 | 241090978 | 34 | 1335917 | |||
| 2024-06-24 | SC 13G | COWEN AND COMPANY, LLC | 0001085146-24-002732 | 005-89992 | 241065404 | 34 | 35964 | |||
| 2024-06-24 | SC 13G | UROGEN PHARMA LTD. | 0000902664-24-004451 | 005-89992 | 241065036 | 34 | 75076 | |||
| 2024-06-18 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-163498 | 001-38079 | 241052894 | 34 | 658109 | 1 | 1 |
| 2024-06-18 | 424B5 | 424B5 | 0001193125-24-163496 | 333-268398 | 241052863 | 33 | 683850 | |||
| 2024-06-17 | 424B5 | 424B5 | 0001193125-24-162621 | 333-268398 | 241048542 | 33 | 685135 | |||
| 2024-06-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-160413 | 001-38079 | 241040336 | 34 | 21600422 | 1 | 1 |
| 2024-06-11 | 4 | FORM 4 | 0001437749-24-019900 | 8178 | ||||||
| 2024-06-11 | 144 | xsl144X01/primary_doc.xml | 0001976408-24-000148 | 001-38079 | 241034572 | 33 | 4121 | |||
| 2024-05-13 | 10-Q | FORM 10-Q | 0001437749-24-016116 | 001-38079 | 24936961 | 34 | 6737362 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-136728 | 001-38079 | 24936949 | 34 | 228500 | 1 | 1 |
| 2024-05-08 | SC 13G/A | il0011407140_050724.txt | 0001086364-24-007581 | 005-89992 | 24925321 | 34 | 12465 | |||
| 2024-04-29 | 10-K/A | FORM 10-K/A | 0001437749-24-013504 | 001-38079 | 24886709 | 34 | 774971 | 1 | 1 | |
| 2024-03-20 | 4 | FORM 4 | 0001437749-24-008707 | 4368 | ||||||
| 2024-03-18 | 144 | xsl144X01/primary_doc.xml | 0001000275-24-000026 | 001-38079 | 24758215 | 33 | 4122 | |||
| 2024-03-14 | 10-K | FORM 10-K | 0001437749-24-007753 | 001-38079 | 24748014 | 34 | 10864467 | 1 | 1 | |
| 2024-03-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-067432 | 001-38079 | 24748011 | 34 | 245862 | 1 | 1 |
| 2024-03-04 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-056770 | 001-38079 | 24712816 | 34 | 22465207 | 1 | 1 |
| 2024-03-01 | 8-K | 8-K | 7.01 | 0001193125-24-054393 | 001-38079 | 24706866 | 34 | 150688 | 1 | 1 |
| 2024-02-22 | SC 13D/A | SC 13D/A | 0001178913-24-000695 | 005-89992 | 24662563 | 34 | 47243 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024007 | 005-89992 | 24640143 | 34 | 99979 | |||
| 2024-02-14 | SC 13G/A | greatpoint-urgn123123a1.htm | 0001172661-24-001527 | 005-89992 | 24639443 | 34 | 112695 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001178913-24-000537 | 005-89992 | 24633417 | 34 | 98887 | |||
| 2024-02-14 | SC 13G | UROGEN PHARMA LTD. | 0000902664-24-001542 | 005-89992 | 24632224 | 34 | 66117 | |||
| 2024-02-13 | SC 13G/A | urgn13ga2024.htm | 0000935836-24-000143 | 005-89992 | 24633412 | 34 | 58767 | |||
| 2024-02-12 | 4/A | FORM 4/A | 0001437749-24-003794 | 4701 | ||||||
| 2024-02-12 | 4/A | FORM 4/A | 0001437749-24-003792 | 5988 | ||||||
| 2024-02-07 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-026699 | 001-38079 | 24604505 | 34 | 21298438 | 1 | 1 |
| 2024-02-05 | 4/A | FORM 4/A | 0001437749-24-003155 | 7559 | ||||||
| 2024-02-05 | 4/A | FORM 4/A | 0001437749-24-003153 | 7563 | ||||||
| 2024-02-02 | 4 | FORM 4 | 0001437749-24-003018 | 20315 | ||||||
| 2024-02-02 | 4 | FORM 4 | 0001437749-24-003016 | 20324 | ||||||
| 2024-02-02 | 4 | FORM 4 | 0001437749-24-003014 | 8803 | ||||||
| 2024-02-02 | 4 | FORM 4 | 0001437749-24-003012 | 5183 | ||||||
| 2024-02-02 | SC 13G | il0011407140_020224.txt | 0001086364-24-006217 | 005-89992 | 24590257 | 34 | 13330 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0001976408-24-000032 | 001-38079 | 24585348 | 33 | 5164 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0001976408-24-000031 | 001-38079 | 24585294 | 33 | 5168 | |||
| 2024-01-17 | 8-K | 8-K | 1.01,8.01 | 0001193125-24-009259 | 001-38079 | 24538594 | 34 | 155426 | 1 | 1 |
| 2024-01-02 | 8-K | 8-K | 1.01 | 0001193125-24-000244 | 001-38079 | 24500297 | 34 | 146327 | 1 | 1 |
| 2023-12-29 | SC 13G | SC 13G | 0001104659-23-130500 | 005-89992 | 231528089 | 34 | 86069 | |||
| 2023-12-05 | UPLOAD | filename1.pdf | 0000000000-23-013213 | 39489 | ||||||
| 2023-11-27 | CORRESP | filename1.htm | 0001193125-23-283042 | 14040 | ||||||
| 2023-11-16 | UPLOAD | filename1.pdf | 0000000000-23-012561 | 43772 | ||||||
| 2023-11-14 | S-8 | S-8 | 0001193125-23-277126 | 333-275547 | 231406684 | 33 | 88573 | |||
| 2023-11-14 | 10-Q | FORM 10-Q | 0001437749-23-031766 | 001-38079 | 231401737 | 34 | 7379197 | 1 | 1 | |
| 2023-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-276676 | 001-38079 | 231401662 | 34 | 244180 | 1 | 1 |
| 2023-09-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-09-15 16:00:00 | 9999999995-23-002681 | 333-274423 | 231260024 | 33 | 1656 | ||
| 2023-09-15 | SC 13G | greatpoint-urgn090823.htm | 0001172661-23-003255 | 005-89992 | 231257708 | 34 | 112576 | |||
| 2023-09-13 | CORRESP | filename1.htm | 0001193125-23-233859 | 6952 | ||||||
| 2023-09-12 | UPLOAD | filename1.pdf | 0000000000-23-010094 | 40170 | ||||||
| 2023-09-11 | 8-K | 8-K | 5.02,5.07 | 0001193125-23-232477 | 001-38079 | 231247933 | 34 | 166428 | 1 | 1 |
| 2023-09-08 | S-3 | S-3 | 0001193125-23-231552 | 333-274423 | 231245496 | 33 | 312395 | |||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025486 | 4873 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025485 | 4815 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025484 | 4832 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025483 | 4828 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025482 | 4847 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025481 | 4821 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025480 | 4844 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025479 | 5087 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025478 | 5088 | ||||||
| 2023-09-08 | 4 | FORM 4 | 0001437749-23-025476 | 5085 | ||||||
| 2023-09-05 | 4 | FORM 4 | 0001437749-23-025204 | 8119 | ||||||
| 2023-08-14 | D | xslFormDX01/primary_doc.xml | 06b | 0001668243-23-000001 | 021-489628 | 231168521 | 33 | 18185 | ||
| 2023-08-10 | 10-Q | FORM 10-Q | 0001437749-23-022879 | 001-38079 | 231157256 | 34 | 6836814 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-208139 | 001-38079 | 231157252 | 34 | 242036 | 1 | 1 |
| 2023-08-04 | SC 13D | SC 13D | 0001140361-23-037975 | 005-89992 | 231142330 | 34 | 195379 | |||
| 2023-08-01 | ARS | urgnars.pdf | 0001437749-23-021418 | 001-38079 | 231132125 | 34 | 4681546 | |||
| 2023-08-01 | DEFA14A | FORM DEFA14A | 0001437749-23-021415 | 001-38079 | 231132052 | 34 | 260919 | |||
| 2023-08-01 | DEF 14A | FORM DEF 14A | 0001437749-23-021412 | 001-38079 | 231132023 | 34 | 1723550 | |||
| 2023-07-28 | 4 | FORM 4 | 0001437749-23-021073 | 4535 | ||||||
| 2023-07-28 | 4/A | FORM 4/A | 0001437749-23-021072 | 4882 | ||||||
| 2023-07-27 | 4 | FORM 4 | 0001437749-23-020905 | 4803 | ||||||
| 2023-07-27 | 3 | FORM 3 | 0001437749-23-020903 | 2598 | ||||||
| 2023-07-27 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-23-195560 | 001-38079 | 231115617 | 34 | 33020733 | 1 | 1 |
| 2023-07-25 | 8-K | 8-K | 5.02 | 0001193125-23-193453 | 001-38079 | 231108767 | 34 | 143969 | 1 | 1 |
| 2023-06-12 | SC 13G/A | SC 13G/A | 0001178913-23-002198 | 005-89992 | 231007192 | 34 | 112196 | |||
| 2023-06-09 | 4 | FORM 4 | 0001437749-23-017046 | 5120 | ||||||
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-141462 | 001-38079 | 23908941 | 34 | 226364 | 1 | 1 |
| 2023-05-11 | 10-Q | FORM 10-Q | 0001437749-23-013767 | 001-38079 | 23908930 | 34 | 6233967 | 1 | 1 | |
| 2023-05-01 | 10-K/A | 10-K/A | 0001193125-23-130561 | 001-38079 | 23874350 | 34 | 693708 | 1 | 1 | |
| 2023-03-24 | 10-K | FORM 10-K | 0001437749-23-007710 | 001-38079 | 23757723 | 34 | 8779433 | 1 | 1 | |
| 2023-03-22 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-076682 | 001-38079 | 23752973 | 34 | 262960 | 1 | 1 |
| 2023-02-28 | 4/A | FORM 4/A | 0001437749-23-004870 | 6972 | ||||||
| 2023-02-28 | 4/A | FORM 4/A | 0001437749-23-004868 | 8950 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001437749-23-004866 | 6393 | ||||||
| 2023-02-13 | SC 13G/A | urgn13ga.htm | 0000935836-23-000137 | 005-89992 | 23615632 | 34 | 59277 | |||
| 2023-02-02 | 4 | FORM 4 | 0001437749-23-002358 | 17184 | ||||||
| 2023-02-02 | 4 | FORM 4 | 0001437749-23-002340 | 7243 | ||||||
| 2023-02-02 | 4 | FORM 4 | 0001437749-23-002338 | 17400 | ||||||
| 2023-02-02 | 4 | FORM 4 | 0001437749-23-002336 | 22474 | ||||||
| 2023-01-23 | 4 | FORM 4 | 0001437749-23-001625 | 6127 | ||||||
| 2022-12-01 | SC 13G | urogen.htm | 0000935836-22-000637 | 005-89992 | 221440887 | 34 | 59734 | |||
| 2022-12-01 | 424B5 | 424B5 | 0001193125-22-296511 | 333-268398 | 221438868 | 33 | 218752 | |||
| 2022-11-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-11-29 16:00:00 | 9999999995-22-003411 | 333-268398 | 221434180 | 33 | 1656 | ||
| 2022-11-23 | CORRESP | filename1.htm | 0001193125-22-291878 | 7642 | ||||||
| 2022-11-22 | UPLOAD | filename1.pdf | 0000000000-22-012636 | 40148 | ||||||
| 2022-11-16 | S-3/A | FORM S-3/A | 0001437749-22-027542 | 333-268398 | 221395651 | 33 | 96945 | |||
| 2022-11-15 | S-3 | FORM S-3 | 0001437749-22-027467 | 333-268398 | 221391798 | 33 | 1576339 | |||
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-281988 | 001-38079 | 221375057 | 34 | 237688 | 1 | 1 |
| 2022-11-10 | 10-Q | FORM 10-Q | 0001437749-22-026727 | 001-38079 | 221375041 | 34 | 6835129 | 1 | 1 | |
| 2022-11-09 | 3 | DW 11082022 FORM 3 | 0001437749-22-026636 | 2617 | ||||||
| 2022-11-09 | 4 | DW 11082022 | 0001437749-22-026635 | 4785 | ||||||
| 2022-11-09 | 8-K | 8-K | 5.02 | 0001193125-22-280620 | 001-38079 | 221370549 | 34 | 143394 | 1 | 1 |
| 2022-11-02 | 4 | MS 11022022 | 0001437749-22-025549 | 8148 | ||||||
| 2022-10-25 | 4 | RN 10252022 | 0001437749-22-024711 | 8566 | ||||||
| 2022-10-21 | 8-K | 8-K | 2.03 | 0001193125-22-266722 | 001-38079 | 221323850 | 34 | 149655 | 1 | 1 |
| 2022-09-16 | 4 | FORM 4 | 0001437749-22-022616 | 6077 | ||||||
| 2022-09-12 | 3 | FORM 3 | 0001437749-22-022163 | 2621 | ||||||
| 2022-09-12 | 4 | FORM 4 | 0001437749-22-022162 | 4795 | ||||||
| 2022-09-12 | 8-K | FORM 8-K | 5.02 | 0001437749-22-022160 | 001-38079 | 221237439 | 34 | 158890 | 1 | 1 |
| 2022-09-02 | 4 | FORM 4 | 0001437749-22-021777 | 6076 | ||||||
| 2022-09-02 | 4 | FORM 4 | 0001437749-22-021776 | 8092 | ||||||
| 2022-08-25 | 4 | FORM 4 | 0001437749-22-021338 | 6389 | ||||||
| 2022-08-25 | 4 | FORM 4 | 0001437749-22-021337 | 8143 | ||||||
| 2022-08-11 | 10-Q | FORM 10-Q | 0001437749-22-020131 | 001-38079 | 221156053 | 34 | 6627480 | 1 | 1 | |
| 2022-08-11 | S-8 | S-8 | 0001193125-22-218027 | 333-266761 | 221153793 | 33 | 80818 | |||
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-218026 | 001-38079 | 221153786 | 34 | 237846 | 1 | 1 |
| 2022-07-08 | SC 13G | il0011407140_070822.txt | 0000834237-22-010336 | 005-89992 | 221075101 | 34 | 12227 | |||
| 2022-06-13 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-22-014892 | 001-38079 | 221012302 | 34 | 363469 | 1 | 1 |
| 2022-06-10 | 4 | AB 06102022 | 0001437749-22-014774 | 4845 | ||||||
| 2022-06-10 | 4 | CB 06102022 | 0001437749-22-014773 | 4787 | ||||||
| 2022-06-10 | 4 | FC 06102022 | 0001437749-22-014772 | 4804 | ||||||
| 2022-06-10 | 4 | SH 06102022 | 0001437749-22-014771 | 4819 | ||||||
| 2022-06-10 | 4 | RN 06102022 | 0001437749-22-014770 | 7127 | ||||||
| 2022-05-17 | DEFA14A | DEFA14A | 0001193125-22-152998 | 001-38079 | 22934476 | 34 | 52349 | |||
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-145810 | 001-38079 | 22907611 | 34 | 229864 | 1 | 1 |
| 2022-05-10 | 10-Q | FORM 10-Q | 0001437749-22-011618 | 001-38079 | 22907591 | 34 | 7578586 | 1 | 1 | |
| 2022-05-03 | 4 | MS 05032022 FORM 4 | 0001437749-22-010701 | 8154 | ||||||
| 2022-05-02 | DEFA14A | FORM DEFA14A | 0001437749-22-010484 | 001-38079 | 22882880 | 34 | 371450 | |||
| 2022-05-02 | DEF 14A | FORM DEF 14A | 0001437749-22-010483 | 001-38079 | 22882866 | 34 | 1813276 | |||
| 2022-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-021524 | 5305 | ||||||
| 2022-03-29 | 3 | FORM 3 SUBMISSION | 0001209191-22-021521 | 8218 | ||||||
| 2022-03-21 | S-8 | S-8 | 0001193125-22-080104 | 333-263729 | 22754296 | 33 | 79879 | |||
| 2022-03-21 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-22-080081 | 001-38079 | 22754260 | 34 | 321181 | 1 | 1 |
| 2022-03-21 | 10-K | FORM 10-K | 0001437749-22-006778 | 001-38079 | 22754237 | 34 | 8576525 | 1 | 1 | |
| 2022-03-08 | 8-K | 8-K | 1.01,2.03 | 0001193125-22-068800 | 001-38079 | 22720522 | 34 | 155117 | 1 | 1 |
| 2022-02-14 | SC 13G/A | AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-22-001901 | 005-89992 | 22632167 | 34 | 82709 | |||
| 2022-02-14 | SC 13G/A | NONE | 0001567619-22-004106 | 005-89992 | 22629006 | 34 | 69387 | |||
| 2022-02-04 | SC 13G/A | SEC SCHEDULE 13G | 0001678858-22-000077 | 005-89992 | 22591241 | 34 | 32812 | |||
| 2022-02-03 | SC 13G/A | il0011407140_020322.txt | 0000834237-22-006257 | 005-89992 | 22589012 | 34 | 13299 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006387 | 13426 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006385 | 13394 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006384 | 18972 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006383 | 16651 | ||||||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005416 | 8837 | ||||||
| 2022-01-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-002305 | 8886 | ||||||
| 2021-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-067440 | 8720 | ||||||
| 2021-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-067439 | 8677 | ||||||
| 2021-11-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-065756 | 4463 | ||||||
| 2021-11-15 | 8-K | 8-K | 1.02,2.02,9.01 | 0001193125-21-329000 | 001-38079 | 211406503 | 34 | 240550 | 1 | 1 |
| 2021-11-15 | 10-Q | FORM 10-Q | 0001437749-21-026620 | 001-38079 | 211406409 | 34 | 5834467 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 8.01 | 0001193125-21-326173 | 001-38079 | 211397715 | 34 | 147985 | 1 | 1 |
| 2021-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-062360 | 8842 | ||||||
| 2021-10-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-061868 | 8841 | ||||||
| 2021-09-13 | 8-K | 8-K | 8.01 | 0001193125-21-270939 | 001-38079 | 211248684 | 34 | 153620 | 1 | 1 |
| 2021-08-05 | S-8 | S-8 | 0001193125-21-237825 | 333-258496 | 211149057 | 33 | 131166 | |||
| 2021-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-235753 | 001-38079 | 211142421 | 34 | 239057 | 1 | 1 |
| 2021-08-04 | 10-Q | 10-Q | 0001564590-21-040510 | 001-38079 | 211142418 | 34 | 8137355 | 1 | 1 | |
| 2021-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-049477 | 8842 | ||||||
| 2021-07-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-048398 | 8841 | ||||||
| 2021-07-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-21-214667 | 001-38079 | 211089300 | 34 | 203184 | 1 | 1 |
| 2021-07-12 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-046344 | 30187 | ||||||
| 2021-07-12 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-046340 | 18871 | ||||||
| 2021-06-09 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-039138 | 6979 | ||||||
| 2021-06-09 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-039137 | 7288 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039136 | 5193 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039135 | 5176 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039134 | 5229 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039133 | 5313 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039132 | 11763 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039131 | 5234 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-039130 | 5208 | ||||||
| 2021-06-08 | 8-K | 8-K | 5.02,5.07,9.01 | 0001564590-21-032093 | 001-38079 | 211001948 | 34 | 513752 | 1 | 1 |
| 2021-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-038842 | 5258 | ||||||
| 2021-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-038841 | 5225 | ||||||
| 2021-05-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-034823 | 14368 | ||||||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033402 | 4450 | ||||||
| 2021-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-033399 | 4973 | ||||||
| 2021-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-159839 | 001-38079 | 21917233 | 34 | 223915 | 1 | 1 |
| 2021-05-13 | 10-Q | 10-Q | 0001564590-21-027210 | 001-38079 | 21917201 | 34 | 7400872 | 1 | 1 | |
| 2021-05-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-029758 | 8843 | ||||||
| 2021-04-28 | DEFA14A | DEFA14A | 0001564590-21-021333 | 001-38079 | 21864183 | 34 | 440726 | |||
| 2021-04-28 | DEF 14A | DEF 14A | 0001564590-21-021330 | 001-38079 | 21864168 | 34 | 2735308 | |||
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0001209191-21-028500 | 8841 | ||||||
| 2021-04-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-027978 | 6662 | ||||||
| 2021-04-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-027977 | 6971 | ||||||
| 2021-03-18 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-085031 | 001-38079 | 21753152 | 34 | 246966 | 1 | 1 |
| 2021-03-18 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-21-085025 | 001-38079 | 21753151 | 34 | 176423 | 1 | 1 |
| 2021-03-18 | 10-K | 10-K | 0001564590-21-014016 | 001-38079 | 21753149 | 34 | 11805081 | 1 | 1 | |
| 2021-02-12 | SC 13G/A | AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-002247 | 005-89992 | 21627355 | 34 | 143703 | |||
| 2021-02-12 | SC 13G | NONE | 0001567619-21-003470 | 005-89992 | 21627093 | 34 | 69429 | |||
| 2021-02-11 | SC 13G/A | SC 13G/A | 0001178913-21-000436 | 005-89992 | 21616702 | 34 | 68423 | |||
| 2021-02-03 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-21-000042 | 005-89992 | 21585369 | 34 | 37346 | |||
| 2021-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-006710 | 7741 | ||||||
| 2021-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-006709 | 7756 | ||||||
| 2021-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-006700 | 7783 | ||||||
| 2021-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-006699 | 13519 | ||||||
| 2021-02-01 | SC 13G/A | il0011407140_013121.txt | 0000834237-21-005462 | 005-89992 | 21574471 | 34 | 13212 | |||
| 2021-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-005460 | 8842 | ||||||
| 2021-01-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-007767 | 001-38079 | 21525095 | 34 | 147517 | 1 | 1 |
| 2021-01-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-005843 | 001-38079 | 21519402 | 34 | 14625181 | 1 | 1 |
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063558 | 4480 | ||||||
| 2020-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-20-061921 | 8846 | ||||||
| 2020-12-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-061812 | 7410 | ||||||
| 2020-12-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-309507 | 001-38079 | 201366969 | 34 | 150994 | 1 | 1 |
| 2020-11-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-296012 | 001-38079 | 201321315 | 34 | 153689 | 1 | 1 |
| 2020-11-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-052224 | 001-38079 | 201296205 | 34 | 435725 | 1 | 1 |
| 2020-11-09 | 10-Q | 10-Q | 0001564590-20-052197 | 001-38079 | 201296120 | 34 | 7791563 | 1 | 1 | |
| 2020-10-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-056066 | 8847 | ||||||
| 2020-10-16 | 4 | FORM 4 SUBMISSION | 0001209191-20-055037 | 17454 | ||||||
| 2020-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-20-053641 | 7734 | ||||||
| 2020-10-05 | 3 | FORM 3 SUBMISSION | 0001209191-20-053637 | 6283 | ||||||
| 2020-10-05 | 4/A | FORM 4/A SUBMISSION | 0001209191-20-053632 | 8168 | ||||||
| 2020-09-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-049937 | 11451 | ||||||
| 2020-09-10 | 3 | FORM 3 SUBMISSION | 0001209191-20-049936 | 6308 | ||||||
| 2020-09-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-241611 | 001-38079 | 201165481 | 34 | 274386 | 1 | 1 |
| 2020-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-049741 | 8855 | ||||||
| 2020-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-20-048883 | 8869 | ||||||
| 2020-08-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-232097 | 001-38079 | 201139071 | 34 | 193968 | 1 | 1 |
| 2020-08-10 | S-8 | S-8 | 0001193125-20-215023 | 333-243750 | 201090240 | 33 | 48883 | |||
| 2020-08-10 | 10-Q | 10-Q | 0001564590-20-038611 | 001-38079 | 201087125 | 34 | 7592966 | 1 | 1 | |
| 2020-08-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-038598 | 001-38079 | 201087067 | 34 | 441294 | 1 | 1 |
| 2020-07-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-043874 | 8867 | ||||||
| 2020-07-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-043873 | 8850 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035684 | 5322 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035682 | 5216 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035680 | 5217 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035679 | 5238 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035678 | 5202 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035677 | 5185 | ||||||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035676 | 5243 | ||||||
| 2020-06-10 | 8-K | 8-K | 4.01,5.02,5.07,9.01 | 0001193125-20-165697 | 001-38079 | 20954860 | 34 | 381906 | 1 | 1 |
| 2020-06-05 | 4 | FORM 4 SUBMISSION | 0001209191-20-034672 | 8857 | ||||||
| 2020-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-20-030900 | 8870 | ||||||
| 2020-05-15 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-143480 | 001-38079 | 20881084 | 34 | 158396 | 1 | 1 |
| 2020-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-029079 | 7416 | ||||||
| 2020-05-07 | 10-Q | 10-Q | 0001564590-20-022352 | 001-38079 | 20854520 | 34 | 6752564 | 1 | 1 | |
| 2020-04-29 | DEFA14A | DEFA14A | 0001564590-20-019415 | 001-38079 | 20827272 | 34 | 268726 | |||
| 2020-04-29 | DEF 14A | DEF 14A | 0001564590-20-019410 | 001-38079 | 20827238 | 34 | 1388905 | |||
| 2020-04-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-025904 | 8850 | ||||||
| 2020-04-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-025903 | 8867 | ||||||
| 2020-04-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-025893 | 8842 | ||||||
| 2020-04-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-108412 | 001-38079 | 20794946 | 34 | 164789 | 1 | 1 |
| 2020-03-23 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-081537 | 001-38079 | 20733561 | 34 | 204772 | 1 | 1 |
| 2020-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-20-016275 | 9386 |
One latest value per concept from companyfacts (303 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 49.05M | 2026-10-28 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 620.40M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.08M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014237 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.18M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014237 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 11.84M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014237 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.31M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014237 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 264.04 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014237 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 4,596.38 | 2026-11-04 | S-8 | 2026-11-04 | 0001437749-26-034945 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 4,596.38 | 2026-11-04 | S-8 | 2026-11-04 | 0001437749-26-034945 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 52.83M | 2026-11-04 | S-8 | 2026-11-04 | 0001437749-26-034945 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-04 | S-8 | 2026-11-04 | 0001437749-26-034945 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-04 | S-8 | 2026-11-04 | 0001437749-26-034945 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 46.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 17.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 117.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 319,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | AccruedBonusesCurrentAndNoncurrent | Accrued Bonuses | USD | 400,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022352 | |
| us-gaap | AccruedRoyaltiesCurrentAndNoncurrent | Accrued Royalties | USD | 6.60M | 2020-03-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 399.60M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 873.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 18.64M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 1.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | Assets | Assets | USD | 271.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 251.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025794 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 3,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025794 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 28.84M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025794 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 6.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 28.84M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025794 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 4.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 51,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 85.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 52.40M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001437749-22-020131 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 72.48M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 90.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 86.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -25.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 52.40M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001437749-22-020131 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 5.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | ILS/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 49.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 49.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 135,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -39.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice | Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price | USD | 135,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001437749-25-006842 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 2.2 | 2017-04-19 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 18.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 196,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 78,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -118,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 70.80M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001437749-22-011618 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 75.00M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001437749-22-011618 | |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 100,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001437749-22-011618 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | Security | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 26,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | pure | 1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 1.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 650,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001564590-19-005323 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 200.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 527,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 153.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 2.60M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 600,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 20.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 13.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 2.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 61,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 198.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 1.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 56,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | Depreciation | Depreciation | USD | 207,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 401,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 234,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 0 | 2004-04-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001437749-23-031766 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.78 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -4.96 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.24 | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.23 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.151 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 16.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 37.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 13.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 168,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | USD | 168,000 | 2017-01-01 | 2017-09-30 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 0 | 2017-09-30 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 | |
| us-gaap | FinanceLeaseImpairmentLoss | Finance Lease, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001437749-25-006842 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 465,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 4.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 2.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 4.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 396,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 509,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 486,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 852,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 1.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 4.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 1.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.137 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -1,000 | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | -100,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 60.20M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | GrossProfit | Gross Profit | USD | 194.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -37.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 35.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -125.11M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 3.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 23.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 605,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -35.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 6.93M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001437749-25-006842 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.05M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-24 | 0001437749-23-007710 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 89,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 175,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 597,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001437749-25-006842 |
| us-gaap | IncomeTaxReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount | USD | 789,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 19.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 84.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 657,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -650,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | 3.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 8.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -303,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 2.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 4,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 1.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | InterestExpenseLongTermDebt | Interest Expense, Long-term Debt | USD | 13.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 3.61M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 200,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 1.56M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 16.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 25.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 2.89M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 10.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | Investments | Investments | USD | 6.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.20M | 2018-01-01 | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 3.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 999,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 301,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 613,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 613,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 913,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 248,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 702,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 49,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedFourYears | Lessor, Operating Lease, Payment to be Received, Year Four | USD | 49,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 49,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear | Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year | USD | 63,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001437749-23-031766 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 49,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-24 | 0001437749-23-007710 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 49,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | Liabilities | Liabilities | USD | 397.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 271.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 74.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 1.75M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 | |
| us-gaap | LiabilityForUncertainTaxPositionsNoncurrent | Liability for Uncertainty in Income Taxes, Noncurrent | USD | 3.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 150.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 189.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | -100,000 | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 67.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 839,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -93.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -39.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -128.48M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 |
| us-gaap | NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | USD | 4.10M | 2015-01-01 | 2015-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -744,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 109.50M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -11.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 717,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.20M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015019 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 2.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 707,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 2.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 590,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 4.53M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.76M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 301,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 348,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.10M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.27M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.118 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 626.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 3.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -226,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -20,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -20,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 8.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -284,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 214,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015019 |
| us-gaap | OtherSellingGeneralAndAdministrativeExpense | Other Selling, General and Administrative Expense | USD | 1.33M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015019 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | PaymentsForProceedsFromShortTermInvestments | Payments for (Proceeds from) Short-term Investments | USD | -35.90M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 215,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 24.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 4.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 186,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | PaymentsToAcquireRestrictedInvestments | Payments to Acquire Restricted Investments | USD | 172,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014016 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 36.00M | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 825,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 17.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 65.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 21.58M | 2015-01-01 | 2015-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 120.00M | 2023-07-26 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 29.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 26.30M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040510 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-24 | 0001437749-23-007710 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 35.90M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 3.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 382,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 5.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 588,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 58.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 9.71M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015019 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 4.10M | 2015-01-01 | 2015-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | RestrictedInvestmentsCurrent | Restricted Investments, Current | USD | 523,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042553 | |
| us-gaap | RestrictedInvestmentsNoncurrent | Restricted Investments, Noncurrent | USD | 178,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -999.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 212.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | Revenues | Revenues | USD | 1.13M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001564590-19-005323 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 456,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 2.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 147.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 2.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 2.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 496,417 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-24 | 0001437749-23-007710 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 122,500 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 1.60M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 9,600 | 2016-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007970 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 27.97 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-24 | 0001437749-23-007710 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 11.52 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 1.83M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 2.69M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-14 | 0001437749-24-007753 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 19.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 68,416 | 2017-01-01 | 2017-12-31 | 2017 | FY | 20-F | 2018-03-15 | 0001564590-18-005876 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 6.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | USD | 1.40M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001437749-25-033468 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -125.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 3.2 | 2017-04-19 | 2018 | Q3 | 6-K | 2018-11-13 | 0001564590-18-029081 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 3,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 11.10M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 3.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 100,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001564590-19-005323 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 1.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 717,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 2.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001437749-25-006842 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 550,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 29.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001437749-26-006234 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 487,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 22.35M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0001437749-22-006778 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 50.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001437749-26-034780 |